^
Association details:
Biomarker:No biomarker
Cancer:Sarcoma
Regimen:AD (dacarbazine + pegylated liposomal doxorubicin)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Uterine sarcoma: Other Recommended Regimens…Doxorubicin/dacarbazine